Benitec Biopharma Inc. Common Stock

BNTC XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

360M

Short interest (May 15)

6.6%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.41%

↓ 3.3%

Available Shares

600K

↑ 8.0%

Price Chart

Company Overview

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001808898

Asset Type: CS

Market Data

Market Cap: $363,468,853

Employees: 19

Status: Active

Short Interest

Current Borrow Fee 0.41%

Range: 0.41% - 0.47%

Available Shares 600K

Range: 550K - 550K

Recent Changes

Fee Change: ↑ 5.3%

Available Change: ↑ 4.8%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime